Sponsor:
Mayo Clinic
Code:
NCT05854303
Conditions
Opioid-Induced Esophageal Dysfunction
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Opioid cessation
No opioid cessation
Brief summary:
Conditions
Opioid-Induced Esophageal Dysfunction
Study ID
NCT05854303
Start date
Sep 18, 2023
Status verified date
Oct, 2025
Completion date
Nov, 2026
Anticipated
Primary completion date
Nov, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
26 participants
Anticipated
Arms
Opioid Cessation
Non-Opioid Cessation
Interventions
Opioid cessation
No opioid cessation
Primary outcome measure
Central contacts
Locations
Mayo Clinic Minnesota
Recruiting
Rochester, Minnesota, United States, 55905
Sponsor
Mayo Clinic
Last update posted
Oct 16, 2025
Last verified
Oct, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2025-10-16.